Cytokine network in peripheral blood mononuclear cells after allogeneic bone marrow transplantation.
Tanaka
J
J
Third Department of Internal Medicine, Hokkaido University School of Medicine, Japan.
Imamura
M
M
Kasai
M
M
Hashino
S
S
Kobayashi
S
S
Noto
S
S
Sakurada
K
K
Asaka
M
M
D016026:Bone Marrow Transplantation / Q000276:immunology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D016207:Cytokines / Q000096:biosynthesis*; D005047:Etoposide / Q000627:therapeutic use; D015870:Gene Expression; D006086:Graft vs Host Disease / Q000276:immunology* / Q000517:prevention & control; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007378:Interleukins / Q000096:biosynthesis; D008214:Lymphocytes / Q000276:immunology*; D008727:Methotrexate / Q000627:therapeutic use; D016133:Polymerase Chain Reaction; D012333:RNA, Messenger / Q000096:biosynthesis; D014184:Transplantation, Homologous; D014916:Whole-Body Irradiation
D016207:Cytokines; D007166:Immunosuppressive Agents; D007378:Interleukins; D012333:RNA, Messenger; D005047:Etoposide; D016572:Cyclosporine; D003520:Cyclophosphamide; D008727:Methotrexate